The FDA says no
2024
In 2024 an FDA advisory panel rejected MDMA-assisted therapy for PTSD over trial-design and conduct concerns, and the agency followed. A reminder that the renaissance is not a straight line.
Source: YouTube
Part of LSD · Watch in the documentary
